Please provide your email address to receive an email when new articles are posted on . Immediate insertion of a cardiac monitor following first cryptogenic stroke was cost-effective in the U.S.

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma Patients age 66 years or older with full Medicare coverage ...